Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [916]

Outcome of third salvage autologous stem cell transplantation in multiple...

Dr Laurent Garderet - Hôpital Saint Antoine, Paris, France

Outcome of third salvage autologous stem cell transplantation in multiple myeloma ( Dr Laurent Garderet - Hôpital Saint Antoine, Paris, France )

Advances in paediatric ALL

Dr Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy

Advances in paediatric ALL ( Dr Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy )

Treating Philadelphia chromosome-positive (Ph ) ALL

Prof Oliver Ottmann - Cardiff University, Cardiff, Wales

Treating Philadelphia chromosome-positive (Ph ) ALL ( Prof Oliver Ottmann - Cardiff University, Cardiff, Wales )

Future horizons in ALL: What should we expect?

Prof Hervé Dombret - Hôpital Saint-Louis, Paris, France

Future horizons in ALL: What should we expect? ( Prof Hervé Dombret - Hôpital Saint-Louis, Paris, France )

Stem cell transplant for geriatric ALL

Dr Mohamad Mohty - Hôpital Saint-Antoine, Paris, France

Stem cell transplant for geriatric ALL ( Dr Mohamad Mohty - Hôpital Saint-Antoine, Paris, France )

Targets for therapy in ETP-ALL

Prof Jan Cools - University of Leuven, Belgium

Targets for therapy in ETP-ALL ( Prof Jan Cools - University of Leuven, Belgium )

The role of autologous transplant in ALL

Prof Sebastian Giebel - Silesian Medical University, Katowice, Poland

The role of autologous transplant in ALL ( Prof Sebastian Giebel - Silesian Medical University, Katowice, Poland )

Next steps for treating breast cancer

Dr Michel Velez - Memorial Healthcare System, Hollywood, FL, USA

Next steps for treating breast cancer ( Dr Michel Velez - Memorial Healthcare System, Hollywood, FL, USA )

Epirubicin and cyclophosphamide before docetaxel in early breast cancer

Dr Bent Ejlertsen - Rigshospitalet Copenhagen, Denmark

Epirubicin and cyclophosphamide before docetaxel in early breast cancer ( Dr Bent Ejlertsen - Rigshospitalet Copenhagen, Denmark )

neoMONARCH: CDK inhibition for HR positive, HER negative breast cancer

Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA

neoMONARCH: CDK inhibition for HR positive, HER negative breast cancer ( Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA )

PARP inhibitory velaparib trialled in BRCA1/2 breast cancer

Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA

PARP inhibitory velaparib trialled in BRCA1/2 breast cancer ( Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA )

PD-1 therapy with eribulin for triple negative MBC

Dr Sara Tolaney - Dana–Farber Cancer Institute, Boston, USA

PD-1 therapy with eribulin for triple negative MBC ( Dr Sara Tolaney - Dana–Farber Cancer Institute, Boston, USA )

More from ecancer